April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
CTG18.1 Trinucleotide Repeat Expansion of TCF4 Gene in Fuchs’ Endothelial Corneal Dystrophy
Author Affiliations & Notes
  • Ahmed Z Soliman
    Ophthalmology, UT Southwestern Medical Center, Dallas, TX
    Ophthalmology, Cairo University, Cairo, Egypt
  • Xin Gong
    Ophthalmology, UT Southwestern Medical Center, Dallas, TX
  • Imran Hussain
    Ophthalmology, UT Southwestern Medical Center, Dallas, TX
  • Chao Xing
    McDermott Center for Human Growth and Development/Center for Human Genetics, UT Southwestern Medical Center, Dallas, TX
  • Vinod V Mootha
    Ophthalmology, UT Southwestern Medical Center, Dallas, TX
    McDermott Center for Human Growth and Development/Center for Human Genetics, UT Southwestern Medical Center, Dallas, TX
  • Footnotes
    Commercial Relationships Ahmed Soliman, None; Xin Gong, None; Imran Hussain, None; Chao Xing, None; Vinod Mootha, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1005. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ahmed Z Soliman, Xin Gong, Imran Hussain, Chao Xing, Vinod V Mootha; CTG18.1 Trinucleotide Repeat Expansion of TCF4 Gene in Fuchs’ Endothelial Corneal Dystrophy. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1005.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Background: Fuchs’ endothelial corneal dystrophy (FECD) is a bilateral, progressive disorder of the endothelium that can result in corneal edema and loss of vision. It is the leading indication for corneal transplantation in the United States and is estimated to affect 4% of the population over the age of forty in this country. Previous studies have documented that the expanded TCF4 CTG 18.1 allele confers a significant risk for FECD. Purpose: To compare the demographics, severity of FECD, and likelihood of undergoing keratoplasty in TCF4 CTG 18.1 expansion positive and negative cases.

 
Methods
 

The trinucleotide repeat polymorphism CTG18.1 was genotyped using a combination of short tandem repeat assay and triplet repeat primed PCR assay. CTG repeat length of ≥ 40 was classified as an expanded CTG18.1 allele. Grading the clinical severity of FECD was done using a modified Krachmer scale. A severity score was created for each patient using the sum of the grades from both eyes. Association of the expanded TCF4 CTG 18.1 allele with the severity of FECD and the likelihood of requiring keratoplasty were evaluated.

 
Results
 

240 subjects with FECD were recruited. Over two thirds of patients were females (N=165, 68.8%) and the majority were Caucasians (N=218, 90.8%). Patients with expansion positive FECD (N=158, 65.8%) had a mean age of 68.32 years ± 13.88 (mean ± SD), 63.9% were females (N=101) and 98.1% were Caucasians (N=155). Patients with expansion negative FECD (N=82, 34.2%) had a mean age of 63.45 years ± 13.18 (mean ± SD), 78.0% were females (N=64) and 76.8% were Caucasians (N=63). Compared with the expansion negative FECD subgroup, patients with the expanded CTG18.1 allele had increased clinical severity of FECD (P<0.0001) and were more likely to undergo keratoplasty (p=0.0004). No difference was found in the prevalence of the expanded allele among familial vs. presumed sporadic cases (p=0.1704).

 
Conclusions
 

The expanded TCF4 CTG 18.1 allele confers significant risk for increased clinical severity of FECD and the likelihood of requiring keratoplasty for visual rehabilitation. The presence of the expanded CTG 18.1 allele was not significantly different among familial and presumed sporadic cases in this cohort.

 
Keywords: 481 cornea: endothelium • 539 genetics • 479 cornea: clinical science  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×